Discontinuation report EPIRUBICIN FOR INJECTION
| Report ID | 126906 |
| Drug Identification Number | 02324091 |
| Brand name | EPIRUBICIN FOR INJECTION |
| Common or Proper name | EPIRUBICIN FOR INJECTION 2mg/ml |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | EPIRUBICIN HYDROCHLORIDE |
| Strength(s) | 2MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 5ML |
| ATC code | L01DB |
| ATC description | CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2020-10-23 |
| Actual discontinuation date | 2020-10-23 |
| Remaining supply date | 2020-10-23 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | Discontinued as of Oct 23 2020 |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2020-10-22 | English | Compare |
| v2 | 2020-10-22 | French | Compare |
| v3 | 2020-10-24 | English | Compare |
Showing 1 to 3 of 3